Skip to main content
Equibles

RA CAPITAL MANAGEMENT, L.P.

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1346824 BOSTON, MA
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$86,996,425
-$217,220 QoQ
Shares Held
10,860,977
0.0% QoQ
Ownership
10.9%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#1
of 208 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. SPRY ranks #25 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 10,281,496 $2,742,280,613
2 PBLS
Parabilis Medicines, Inc.
 28,933,371 $791,906,364
3 RYTM
Rhythm Pharmaceuticals, Inc.
 6,666,837 $740,218,912
4 PCVX
Vaxcyte, Inc.
 11,474,599 $667,018,439
5 SION
Sionna Therapeutics, Inc.
 9,905,045 $435,722,929
6 TYRA
Tyra Biosciences, Inc.
 12,198,625 $389,624,082
7 EWTX
Edgewise Therapeutics, Inc.
 8,392,730 $340,996,619
8 NAMS
NewAmsterdam Pharma Co N.V.
 9,883,524 $330,779,298

All Filings in SPRY

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $86,996,425 10,860,977
2026-03-31 $87,213,645 10,860,977
2025-12-31 $126,530,382 10,860,977
2025-09-30 $109,152,818 10,860,977
2025-06-30 $189,524,048 10,860,977
2025-03-31 $136,631,090 10,860,977
2024-12-31 $114,583,307 10,860,977
2024-09-30 $157,484,166 10,860,977
2024-06-30 $92,426,914 10,860,977
2024-03-31 $110,999,184 10,860,977
2023-12-31 $51,839,035 9,459,678
2023-09-30 $35,757,582 9,459,678
2023-06-30 $20,164,842 3,009,678
2023-03-31 $19,593,003 3,009,678
2022-12-31 $25,672,553 3,009,678
2021-12-31 $11,602,958 1,742,186
2021-09-30 $17,387,016 1,742,186
2021-06-30 $53,816,125 1,742,186
2021-03-31 $76,011,575 1,742,186
2020-12-31 $80,732,899 1,742,186